The LRRC30 activators are a diverse set of chemicals fundamentally aimed at modulating the cellular balance between phosphorylation and dephosphorylation. Their principle function aligns with the anticipated serine/threonine phosphatase activity of LRRC30 and its pivotal role in intracellular signaling dynamics. Phosphatases and kinases work in tandem, setting the rhythmic oscillation of intracellular signals. Therefore, substances like Okadaic acid, Calyculin A, and Cantharidin are paramount. These are of particular phosphatases and, by suppressing them, can indirectly underscore the significance of LRRC30's phosphatase activity, amplifying its role.
Diversely, chemicals such as Caffeine and Anisomycin channel influence on phosphatase activity by targeting distinct signaling pathways. Caffeine, for instance, is an adenosine receptor antagonist and indirectly boosts intracellular phosphatase activity. In a parallel stride, Anisomycin activates the JNK signaling pathway, which may instigate conditions that amplify LRRC30's phosphatase function. Similarly, EGF, a growth factor, and PMA, an activator of PKC, represent chemicals that emphasize kinase-driven processes. Their function can indirectly create an environment where LRRC30's phosphatase action becomes indispensable for cellular homeostasis. Further down the pathway-centric approach, agents like Zinc Pyrithione and A23187 stand out. The former boosts the MAPK pathway, a central signaling cascade in cells, while the latter affects calcium signaling, a universal cell signaling mediator. Such perturbations in primary signaling mechanisms invariably intertwine with phosphatase entities like LRRC30. Lastly, H89, IBMX, and Roscovitine, by targeting kinases and associated pathways, modulate the cellular balance of phosphorylation, emphasizing the checks and balances role phosphatases like LRRC30 play in maintaining signaling harmony. Through their actions, these chemicals underscore the relevance and indispensability of LRRC30 in the intricate signaling network of the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A potent phosphatase inhibitor, it can upregulate phosphatase activity indirectly by blocking competing phosphatases, possibly enhancing LRRC30 function. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Like Okadaic acid, Calyculin A inhibits certain phosphatases. This might indirectly amplify LRRC30’s phosphatase activity by reducing competition. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
A phosphatase inhibitor. By suppressing other phosphatases, it can indirectly elevate the prominence of LRRC30’s enzymatic role in the cell. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Recognized to influence intracellular signaling, it can enhance phosphatase activity, potentially promoting LRRC30’s role in signal transduction. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates the JNK signaling pathway, possibly creating conditions conducive for LRRC30's serine/threonine phosphatase activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activator of Protein Kinase C (PKC). By modifying kinase activity, it might indirectly necessitate LRRC30's counterbalancing phosphatase action. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Boosts the MAPK pathway, a major signaling cascade, potentially necessitating the serine/threonine phosphatase activity of LRRC30. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore affecting calcium signaling. Such calcium perturbations can indirectly require regulation by phosphatases like LRRC30. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor that increases intracellular cAMP, potentially eliciting pathways where LRRC30 functions as a regulatory element. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
CDK inhibitor affecting cell cycle-related kinases. The disrupted kinase activity can indirectly highlight the regulatory function of LRRC30. | ||||||